| TTM
|
12/31/2025
|
12/31/2024
|
12/31/2023
|
12/31/2022
|
|
|---|---|---|---|---|---|
| Total Revenue
|
523,860 | 554,689 | 574,382 | 584,760 | 536,343 |
|
Cost of Revenue
|
-52,178 | -64,131 | -86,876 | -88,992 | -86,619 |
|
Gross Profit
|
471,682 | 490,558 | 487,506 | 495,768 | 449,724 |
| Selling, General and Administrative Expenses
|
-123,372 | -158,748 | -145,685 | -156,561 | -170,073 |
|
Research and Development Expenses
|
-312,665 | -330,169 | -362,111 | -359,215 | -377,264 |
|
Operating Income/Expenses
|
-436,037 | -488,917 | -507,796 | -515,776 | -547,337 |
|
Total Operating Profit/Loss
|
35,645 | 1,641 | -20,290 | -20,008 | -97,613 |
| Total Net Finance Income/Expense
|
4,684 | 1,248 | 8,749 | 7,740 | -401 |
| Net Investment Income
|
-281 | -- | -281 | -1,740 | 3,219 |
| Irregular Income/Expenses
|
-25,000 | -- | -- | -- | -- |
|
Non-Operating Income/Expenses, Total
|
4,684 | 1,248 | 8,749 | 6,000 | 2,818 |
|
Pretax Income
|
40,329 | 2,889 | -11,541 | -14,008 | -94,795 |
|
Provision for Income Tax
|
-9,220 | -9,285 | -5,744 | -7,000 | -7,940 |
|
Net Income from Continuing Operations
|
31,109 | -6,396 | -17,285 | -21,008 | -102,735 |
|
Net Income after Extraordinary Items and Discontinued Operations
|
31,109 | -6,396 | -17,285 | -21,008 | -102,735 |
|
Net Income after Non-Controlling/Minority Interests
|
31,109 | -6,396 | -17,285 | -21,008 | -102,735 |
|
Net Income Available to Common Stockholders
|
31,109 | -6,396 | -17,285 | -21,008 | -102,735 |
|
Diluted Net Income Available to Common Stockholders
|
31,109 | -6,396 | -17,285 | -21,008 | -102,735 |
| Basic EPS
|
0.25 | -0.05 | -0.14 | -0.16 | -0.80 |
| Diluted EPS
|
0.24 | -0.05 | -0.14 | -0.16 | -0.80 |
|
Basic Weighted Average Shares Outstanding
|
120,920.5710 | 124,117 | 124,021 | 128,841 | 127,849 |
|
Diluted Weighted Average Shares Outstanding
|
129,904.7500 | 128,461 | 127,696 | 132,427 | 130,118 |
| Income Statement, Supplemental
|
|||||
|
EBIT
|
35,645 | -2,076 | -20,571 | -21,747 | -94,002 |
|
EBITDA
|
52,741 | 15,916 | 14,982 | 21,869 | -37,002 |
|
Normalized EBITDA
|
66,412 | 54,941 | 21,469 | 38,897 | -8,178 |
|
Normalized Income
|
41,654.5360 | 635.1920 | -8,604.3420 | -12,410.4460 | -90,191.4900 |
|
Total Unusual Items
|
13,671 | 9,476 | 11,699 | 11,587 | 16,905 |
|
Total Unusual Items Excluding Goodwill
|
13,671 | 9,476 | 11,699 | 11,587 | 16,905 |
|
Tax Effect of Unusual Items
|
3,125.4640 | 2,444.8080 | 3,018.3420 | 2,989.4460 | 4,361.4900 |
12/31/2022 - 5/27/2005
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade